Researchers report encouraging results from experimental antiviral targeting Marburg virus
The Marburg virus, a relative of the Ebola virus, causes a serious, often-fatal hemorrhagic fever.
Pharmaceutical Industry News
Novel vaccination regimen shown to be effective in preventing malaria
A three-dose regimen of Plasmodium falciparum sporozoites under chemoprophylaxis (PfSPZ-CVac) was shown to be safe, well tolerated and highly effective in a Phase II trial.
Technimark Will Manufacture and Package Innovative Nasal Swabs to Support Medical Community
Technimark has partnered with Rhinostics and a P&G subsidiary, iMFLUX, to produce, package and distribute individually packaged medical-grade polypropylene nasal swabs to help healthcare professionals and researchers detect and diagnose potential infections such as COVID-19.
Nasal spray shown to be effective in reducing COVID-19 transmission
The algae-derived NasitrolTM nasal spray reduced the incidence of COVID-19 in intensive care unit (ICU) workers to one percent in a clinical trial.
Tecentriq approved for first-line metastatic NSCLC
Roche’s checkpoint inhibitor Tecentriq has gained a new approval from the European Commission, for the first-line treatment of certain patients with metastatic non-small cell lung cancer (NSCLC), its fourth indication in this cancer type.
Journey from Aquarium-to-Bedside to Treat Genetic Epilepsies
Emerging from stealth mode with a pipeline of FDA and EMA Orphan Drug Designation candidates, Epygenix Therapeutics Inc. is poised to become the first biopharmaceutical company to commercialize epilepsy drugs discovered in zebrafish.
New Study Confirms the Stability and Potency of a Novel Formulation of Liquid Levothyroxine
A new study of the potency and stability of liquid formulations of levothyroxine is being presented at the Pediatric Endocrine Society (PES) Annual Meeting.
Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation
Bexson Biomedical, Inc., a research-stage company developing therapies and delivery solutions for pain management, addiction and mental health indications, announced today that the U.S. Patent and Trademark Office (USPTO)
Signature Biologics™ Research & Development Staff Published Advanced Findings on COVID-19
Signature Biologics, LLC., today announced that its research on the immunomodulatory properties of mesenchymal stem cells derived from human umbilical cord (hUC-MSCs) has been published in the Journal of Translational Medicine.
Meijer Pharmacies Have Administered more than One Million COVID-19 Vaccines
Meijer pharmacies have crossed the threshold of one million vaccine doses administered through the retailer's in-store clinics and are now launching a "walk-up" vaccine program at all Meijer locations.